Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $5,031 - $6,023
-41 Reduced 2.6%
1,536 $219,000
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $38,495 - $51,241
-377 Reduced 19.29%
1,577 $202,000
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $171,522 - $206,049
1,954 New
1,954 $202,000
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $38,264 - $46,253
-411 Reduced 32.59%
850 $94,000
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $7,006 - $8,849
-83 Reduced 6.18%
1,261 $121,000
Q2 2021

Jul 12, 2021

SELL
$67.66 - $84.76 $22,666 - $28,394
-335 Reduced 19.95%
1,344 $113,000
Q4 2020

Feb 04, 2021

BUY
$63.89 - $73.8 $107,271 - $123,910
1,679 New
1,679 $117,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Graves Light Lenhart Wealth, Inc. Portfolio

Follow Graves Light Lenhart Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graves Light Lenhart Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Graves Light Lenhart Wealth, Inc. with notifications on news.